Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06932848

The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus

Led by Chulalongkorn University · Updated on 2026-03-06

30

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This randomized, double-blind clinical trial evaluates the therapeutic effects of curcumin in nanogels compared to 0.1% fluocinolone acetonide oral paste in the management of atrophic-erosive oral lichen planus (OLP). The study aims to determine whether curcumin nanogels, a natural treatment with enhanced bioavailability, are as effective and better tolerated than standard corticosteroid therapy.

CONDITIONS

Official Title

The Therapeutic Effect of Curcumin in Nanogels Compared to 0.1% FAO in the Management of Oral Lichen Planus

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Ability to provide written informed consent
  • Clinically and histopathologically confirmed diagnosis of erosive or atrophic oral lichen planus
  • Presence of symptoms with pain score greater than 0 at baseline
  • Ability to communicate and follow instructions
  • Willingness to apply oral paste treatment and follow the study protocol
Not Eligible

You will not qualify if you...

  • Pregnancy or breastfeeding
  • Current orthodontic treatment
  • Uncontrolled diabetes mellitus (HbA1c > 7% or fasting plasma glucose > 130 mg/dL)
  • Use of anticoagulant or antiplatelet medications
  • Severe dry mouth (Challacombe score > 7)
  • History of gastric ulcers, duodenal ulcers, or gallstones
  • Presence of any active cancer or infection
  • Use of topical or systemic treatment for oral lichen planus in the past 2 weeks
  • Current use of immunosuppressant medications
  • Known allergy to corticosteroids or herbal agents such as turmeric
  • Diagnosis of oral lichenoid contact lesion or graft-versus-host disease (GVHD)
  • History of allogeneic bone marrow transplantation
  • Current smoker

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Faculty of Dentistry, Chulalongkorn University

Bangkok, Thailand, 10400

Actively Recruiting

Loading map...

Research Team

T

Tossapol Maneethorn, D.D.S.

CONTACT

P

Pirawish Limlawan, D.D.S., Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here